TRPM2 is a member of the transient receptor potential melastatin (TRPM)-related ion channel family. The activation of TRPM2 induced by oxidative/nitrosative stress leads to an increase in intracellular free Ca 2+ . Although further progress in understanding TRPM2's role in cell and organism physiology would be facilitated by isolation of compounds able to specifically modulate its function in primary cells or animal models, no cell-based assays for TRPM2 function well suited for high-throughput screening have yet been described. Here, a novel suspension B lymphocyte cell line stably expressing TRPM2 was used to develop a cellbased assay. The assay uses the Ca 2+ -sensitive fluorescence dye, Fluo-4 NW (no wash), to measure TRPM2-dependent Ca 2+ transients induced by H 2 O 2 and N-methyl-N′-nitrosoguanidine in a 96-well plate format. Assay performance was evaluated by statistical analysis of the Z′ factor value and was consistently greater than 0.5 under optimal conditions, suggesting that the assay is very robust. For assay validation, the effects of known inhibitors of TRPM2 and TRPM2 gating secondary messenger production were determined. Overall, the authors have developed a cell-based assay that may be used to identify TRPM2 ion channel modulators from large compound libraries. (Journal of Biomolecular Screening 2008:54-61) 
INTRODUCTION
T HE BIVALENT ION CA 2+ is a critical secondary messenger involved in many physiological and signal transduction processes within a cell. These signals are generated by both release of Ca 2+ from intracellular stores and by entry of extracellular Ca 2+ . Extracellular Ca 2+ entry is an especially important component of these signals, as it is often required to sustain cytosolic Ca 2+ at a concentration necessary for the full activation of Ca 2+ -dependent signaling events.
TRPM2 is a member of the transient receptor potential melastatin (TRPM)-related family. 1 It is a voltage-independent Ca 2+permeable cation channel. 1 TRPM2's primary structure consists of an N-terminal TRPM domain of as yet unknown function, a nonselective TRP superfamily ion channel pore, and a C-terminal domain homologous to the NUDT9 adenosine diphosphate (ADP)-ribose hydrolase (which is thus designated the NUDT9-H domain). [2] [3] [4] [5] TRPM2 gating requires an intact NUDT9-H domain and is presently thought to be induced through binding of ADPribose to the NUDT9-H domain. 4, 5 In TRPM2-expressing cells, TRPM2-dependent increases in cytosolic Ca 2+ can be generated by exposure of TRPM2-expressing cells to reactive oxygen species (ROS) and reactive nitrogen species (RNS), 6, 7 and ROS/RNS are thought to act by promoting accumulation of free cytosolic ADPribose as a secondary messenger. 8, 9 TRPM2 mRNA is highly expressed in the brain 10 and in granulocytes and cells of the monocytic lineage, including neutrophils and macrophages. 2, 3, 5, 11 Native TRPM2 currents have been recorded from the U937 monocyte cell line, primary human neutrophils, Jurkat T cells, microglia, and CRI-G1 insulinoma cells. 3, 10, 12 However, the physiological and cell biological function of TRPM2-mediated Ca 2+ signals in all of these different cell types is poorly understood due to a lack of tools for specific modulation of TRPM2 function. The development of specific small molecular modulators of TRPM2 channels would provide important tools for use in understanding TRPM2's role in the physiology and pathophysiology of oxidative/nitrosative stress and could potentially lead to the development of clinically useful therapeutics for pathophysiologic situations in which ROS/RNS stress-induced TRPM2 gating is implicated in cell damage.
The isolation of ion channel modulators requires a cellbased high-throughput screening (HTS) assay in which the cell response is dominated by the channel of interest. Published cellular systems for measuring TRPM2-dependent responses have used slowly growing adherent cell lines that have exhibited very small peak versus basal responses and prolonged response latencies 4, 13 and therefore would likely be of limited utility in HTS for TRPM2 modulators. We therefore evaluated the performance of a suspension DT40 cell line stably transfected with TRPM2 in a 96-well format assay applicable for HTS. We found that increases in cytosolic Ca 2+ generated by exogenously applied ROS/RNS could be reliably monitored using the Ca 2+ -sensitive dye, Fluo-4 NW (no wash), and were highly specific for TRPM2 expression. Using the Fluo-4 NW assay, we varied a number of conditions, including cell line, plating method, cell seeding density/well, dye loading concentration, dye loading duration, dye loading temperature, plate type, and measurement temperature, so as to optimize assay performance according to the statistical parameter Z′ factor. 14 As further validation, the effects of the TRPM2 channel blocker N-(P-amylcinnamous) anthranilic acid (ACA), as well as the poly ADP-ribose polymerase (PARP) inhibitor 2-(4-methyl-piperazin-1-yl)-5H-benzo (1, 5) naphthyridin-6-one (GPI-16539), which abrogates adenosine diphosphate ribose (ADPR) accumulation in response to ROS/RNS, were determined using optimal assay conditions. Overall, the optimized screening method demonstrates a Z′ consistently greater than 0.5 and thus offers a robust and sensitive method for the identification of TRPM2 ion channel modulators.
MATERIALS AND METHODS
To examine the effects of different cell lines on the assay outcome, we first generated constitutively TRPM2-expressing DT40 cells and HEK-293 cells by transfecting the respective wild-type (WT) cell lines with a plasmid construct that placed the TRPM2 cDNA under control of the chicken β actin promoter. 4 Single clones with various levels of TRPM2-dependent currents were grown out under puromycin (1 μg/mL for HEK-293 cells and 0.5 μg/ml for DT40 cells) selection. Clones with the highest level of TRPM2 expression (~6-8 nA of current elicited by 100 μM ADP-ribose under unbuffered Ca 2+ conditions under whole-cell patch-clamp configuration) were chosen for further experiments. Clonally selected DT40 B lymphocytes and HEK-293 cells constitutively expressing wild-type TRPM2 were cultured using standard conditions in medium supplemented with 10% fetal bovine serum (FBS; Mediatech, Inc., Herndon, VA), 10 units/mL penicillin/streptomycin (Mediatech, Inc.), and 2 mM glutamine (Mediatech, Inc.). The medium used for HEK-293 cells is Dulbecco's modified Eagle's medium (DMEM; Mediatech, Inc.). RPMI 1640 Medium (Mediatech, Inc.) was used for DT40 B lymphocytes and also supplemented with 2% chicken serum (Invitrogen, Carlsbad, CA) and 50 μM beta mercaptoethanol (Sigma, St. Louis, MO).
Cells were then seeded in the 96-well plate. HEK-TRPM2 cells were plated in phenol red-free DMEM medium at the density of 50,000 cells/well in 25 μL and were incubated overnight to allow the cells to adhere to the plate. The following day, the cells were loaded with an equal volume (25 μL) of Fluo-4 NW, or the media were removed from the wells and replaced with 50 μL of Fluo-4 NW diluted 2-fold in Hank's balanced salt solution (HBSS) supplemented with 25 mM HEPES. For seeding DT40 B lymphocytes in the 96-well plate, cells were centrifuged at 2000 rpm for 5 min to remove the growth medium and were resuspended in HBSS supplemented with 25 mM HEPES buffer containing Fluo-4 NW. Cells were then dispensed into the assay plates at a final cell density of 250,000 cells/well in 50 μL. After loading the Fluo-4 NW, cells were incubated at 37 °C for 30 min, then at room temperature for an additional 30 min or until they could be assayed at room temperature. When the Ca 2+ response was measured at 37 °C, plates were incubated for 45 to 60 min at 37 °C, then directly used for the assay at 37 °C. Then, 500 μM N-methyl-N′nitrosoguanidine (MNNG) was used as the TRPM2 channel activator.
The Fluo-4 NW Calcium Assay Kit was obtained from Molecular Probes (Eugene, OR). The assay buffer used for the experiments is HBSS (Invitrogen) supplemented with HEPES buffer (Invitrogen). Assay plates used were tissue culture-treated TPP white 96-well microplates (Midwest Scientific, Valley Park, MO), black with clear-bottom tissue culture-treated isoplate (PerkinElmer, Waltham, MA), and black with clear-bottom tissue culture-treated half-area microplates (Greiner Bio-One, Monroe, NC). MNNG (Sigma) and ACA (BIOMOL, Plymouth Meeting, PA) were stored in DMSO at a 100-mM concentration and kept at -20 ºC. H 2 O 2 (Sigma) was prepared fresh on the day of the experiments. GPI-16539 was synthesized and purified as described previously, stored in DMSO in a 10-mM concentration, and diluted to the indicated concentrations in assay buffers. 15 A Wallac VIC-TOR3 fluorescence microplate reader equipped with an injector (PerkinElmer) was used for the fluorescence measurements. The excitation/emission filter pair (485/535 nm) was used in the experiments, with a 0.1-s measuring time per data point. The injector speed was set at 5. The reading was repeated 60 times.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), immunoprecipitation, and immunoblotting were performed using standard methods as described in the figure legends. For patch-clamp experiments, cells were kept in standard Ringer's solution (in mM): 145 NaCl, 2.8 KCl, 1 CaCl, 2 MgCl, 10 glucose, and 10 HEPES-NaOH (pH7.2). Standard pipette-filling solution contained (in mM) the following: 145Csglutamate, 8 NaCl, 1 MgCl, 10 Cs-EGTA, and 10 HEPES-CsOH (pH 7.2 adjusted with CsOH). Patch-clamp experiments were performed in the whole-cell configuration at room temperature. Data were acquired with Pulse software controlling an EPC-9 amplifier (HEKA). Voltage ramps of 50 ms spanning the voltage range from -100 mV to +100 mV were delivered from a holding potential of 0 mV at rate of 0.5 Hz over a period of 200 s to 400 s. All voltages were corrected for a liquid junction potential of 10 mV between external and internal solution when internal solutions contained glutamate. Currents were filtered at 2.3 kHz and digitized at 100-μs intervals. Capacitive currents and series resistance were determined and corrected before each voltage ramp.
Assay performance was judged by calculating the Z′ factor value 14 and coefficient of variation (CV). 16 
Signal-to-background ratio (S/B) was also used as a reference to evaluate the performance of the assay: S/B = M c+ /M c-. SD c+ and SD c-represent standard deviation (SD) for the positive control and negative control, respectively. M c+ and M c-represent the mean for the positive control and negative control, respectively. Microsoft Excel was used to collect the screening data, and IgorPro was used for generating graph plots.
RESULTS AND DISCUSSION
The expression of TRPM2 in HEK-293 and DT40 transfectants was analyzed by Western blotting, and clones with comparable levels of TRPM2 protein ( Fig. 1A) and ADPR-induced currents (Fig. 1B) were chosen for further characterization. Importantly, electrophysiologic analysis of ADPR-evoked currents in the DT40-TRPM2 and HEK-TRPM2 cells showed the I/V relationship of the currents to be identical to that observed in previously published analyses of human TRPM2, 2,4 as well as indistinguishable from each other (e.g., see I/V curves in Fig. 1C) , thus validating the use of the cell lines in HTS programs for modulators of native TRPM2 channels. ROS/RNSinduced responses in the optimal HEK-TRPM2 and DT40-TRPM2 clones were next compared using a Fluo-4 NW Ca 2+ flux assay to evaluate which cell line possessed superior characteristics for HTS. As shown in Figure 2A ,B, TRPM2dependent Ca 2+ transients are activated in response to cellular exposure to an artificial reactive nitrogen stress (500 μM MNNG 4 ) in both HEK-TRPM2 cells and DT40-TRPM2 cells. However, Ca 2+ transients following treatment of DT40-TRPM2 cells were larger and developed much more rapidly than those following treatment of HEK-TRPM2 cells, generating a Z′ factor value of greater than 0.5 within a few tens of seconds after initiation of the transient (n = 24; Fig. 2B, left) . Although the Z′ factor value from the HEK-293 cell assay was also close to 0.5 ( Fig. 2A, left) , HEK-293 cells exhibited a much longer response latency and a lower response amplitude. Furthermore, a major drawback of the HEK-TRPM2 system was that optimal responses required removal of the plating media ( Fig. 2A; compare left and right panels). Overall, the DT40-TRPM2 assay consistently generated a larger and more rapidly developing TRPM2-dependent Ca 2+ transient in response to the 500-μM MNNG stimulus and was also more conveniently implemented in a 96-well plate format as it avoided the necessity for removal of plating media. Therefore, the DT40-TRPM2 assay was selected for further assay analysis and optimization.
As Ca 2+ transients were consistently stable 300 s after MNNG stimulation of DT40-TRPM2 cells (Fig. 2B, left) , the response from this point was selected for analysis of optimization experiments. The first parameter selected for optimization was cell density. DT40-TRPM2 cells were seeded at densities of 125,000 cells/well, 250,000 cells/well, and 500,000 cells/well, respectively, followed by evaluation of ROS/RNS-induced Ca 2+ transients in the 96-well plate format. As shown in Figure 3A , the highest signal was obtained from the densely seeded wells: 500,000 cells/well. However, the signal from the densely seeded wells produced a higher standard deviation, and therefore the Z′ factor value was lower than 0.5 (n = 24). In comparison, a cell seeding density of 250,000 cells/well produced an easily detectable and more consistent well-to-well signal and thus yielded a higher value of the Z′ factor (Z′ factor value consistently >0.5, n = 24). These experiments suggest that a cell density >250,000/well is detrimental to the assay response and that an HTS assay would benefit from limitation of cell plating density to between 125,000 and 250,000 per well.
To determine whether the assay would benefit from use of plates specifically set up for HTS, a set of experiments was performed to determine the relationship between the application of plate type and the assay performance. As shown in Figure 3B , signal windows obtained from the black isoplate and the black half-area 96-well plate were indistinguishable from the signal window obtained from the transparent plate. All 3 types of plates supported excellent assay results, as indicated by the Z′ factor value larger than 0.5 (Fig. 3B, n = 24) . However, the black isoplate produced a more stable background signal for a longer period of time (up to 3 h). Therefore, application of the black isoplate would potentially allow more consistent assay performance under "real-life" HTS conditions in which the assay has to be performed a long time period after the cells have been loaded with the fluorescence Ca 2+ indicator and plated.
Most compound libraries are solubilized in DMSO. Different cell lines have different DMSO tolerance, and this can be an important variable that directly affects the selection of the compound screening concentrations. We therefore carried out a DMSO tolerance study on the DT40-TRPM2 cell line. As shown in Figure 3C , the TRPM2 Fluo-4 NW assay in DT40-TRPM2 cells tolerated up to 2% DMSO with no apparent changes in control signals or loss in signal amplitude over time. Statistical analysis of plates was also performed: As shown in Figure 3C , the Z′ factor value of the assay was greater than 0.5 at all DMSO concentrations tested, (n = 24), indicating that the assay has a high level of stability to varying DMSO concentrations.
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Some published reports suggest that the optimal temperature for TRPM2 activation is near body temperature. 17 To experimentally assess the influence of temperature on ROS/RNS-induced TRPM2 gating in our Fluo-4 NW Ca 2+ assay, we incubated the assay plate at 37 °C for 1 h and then performed the plate reader assay at 37 °C. We observed that the assay yielded a faster response latency and larger total signal magnitude when performed at 37 °C. However, we also observed that performing the assay at 37 °C led to a background Ca 2+ signal in control DT40 cells lacking TRPM2 expression ( Fig. 3D) . As this small background signal would contribute to the signal measured in the DT40-TRPM2 cells under the same conditions, it was used for Z′ factor calculations, resulting in the overall Z′ being lower than 0.5 (n = 24) at the 37 °C assay temperature (Fig. 3D) . Although use of unstimulated 500 μM-TRPM2 cells for Z′ calculation would yield a higher Z′ value, the use of the control DT40 cells provides an important correction for TRPM2-independent background responses occurring at 37 °C and thus is a more conservative assessment of assay performance under these conditions. Overall, these experiments indicate that the Fluo-4 NW assay is best used at room temperature, despite the longer latency for response development.
TRPM2-dependent Ca 2+ transients are activated in response to cellular exposure to a variety of forms of ROS and RNS. 4, 6, 8, 9 Two robust and easily obtained TRPM2 activators are H 2 O 2 as a model ROS (typically used at 100-1000 μM) and MNNG as a model RNS (typically used at 100-500 μM). As preliminary experiments suggested that concentrations of H 2 O 2 > 100 μM and MNNG > 500 μM led to background responses in nontransfected DT40 cells, we compared the responses produced by 100 μM H 2 O 2 and 500 µM MNNG in our Fluo-4 NW assay using DT40-TRPM2 cells. As shown in Figure 4A (right) , the S/B ratio from cells treated with 100 μM H 2 O 2 was lower than those from the cells treated with 500 μM MNNG; similarly, the Z′ factor was higher with the assay using 500 μM MNNG than the assay with application of 100 μM H 2 O 2 (Fig. 4A, left) . Therefore, MNNG appears to be the better of the 2 TRPM2 activators for use in an HTS program and was used as our standard TRPM2 ion channel activator for further HTS assay development.
Time (Seconds)
Time ( For the determination of the assay signal window, we performed experiments using different concentrations of MNNG to determine the dose-response relationship for MNNG-induced Ca 2+ transients in DT40-TRPM2 cells (Fig. 4B, right) . The EC 50 for MNNG was 70 μM when used as the TRPM2 activator in DT40-TRPM2 cells. However, the concentration of 500 μM MNNG was considered the best condition for HTS implementation of the assay because it produced stable TRPM2-dependent Ca 2+ transients, which reached their maximum amplitude with the shortest response latency (Fig. 4B, right) , both important properties for the execution of HTS for TRPM2 ion channel modulators from large compound libraries.
To assess the assay signal window variability and reproducibility under the condition of applying 500 μM MNNG, we analyzed the experiments from separate days containing several plates/day to determine the plate-to-plate and day-to-day variation. As shown in Figure 4B (left) , on a day-to-day basis, the Z′ factor is greater than 0.5 (n = 24), indicative of robust assay performance. We also observed that the standard deviation from the plate-to-plate analysis was greater than the standard deviations from well-to-well and day-to-day analysis. We attribute this to the assay being performed at different periods of time after cell loading and plating with the fluorescence Ca 2+ indicator Fluo-4 NW. The effect of the wait between dye loading and assay can also be seen as an increase in basal signal from wells seeded with either DT40-TRPM2 cells or DT40 control cells with increasing incubation time. Thus, minimization of this time is an important consideration in application of this assay in HTS.
The ability of our 96-well plate assay to detect pharmacologic TRPM2 channel modulation was evaluated for the reported TRPM2 channel blocker ACA 18 and the PARP inhibitor 2-(4methyl-piperazin-1-yl)-5H-benzo (1, 5) naphthyridin-6-one (GPI-16539), which prevents accumulation of the TRPM2 gating secondary messenger ADP-ribose. 4, 15 As shown in Figure 4C , both compounds dose dependently inhibited 500-μM MNNGmediated gating of TRPM2 activation. Although it has been reported that the half-maximal inhibitory concentration of ACA (IC 50 ) for the H 2 O 2 -induced Ca 2+ transient in HEK-293 cells transfected with TRPM2 was 1.7 μM, 18 in our DT40-TRPM2 cells, the IC 50 of ACA for the 500-μM MNNG-induced TRPM2-dependent Ca 2+ transient was 12 μM (Fig. 4C, left) . The reason for this difference is unclear-the 500-μM MNNG concentration we chose, although well above the EC 50 of the fluorescence response magnitude, would not be expected to influence the IC 50 for ACA, as MNNG indirectly induces TRPM2 activation through accumulation of ADP-ribose. 8 Potential explanations for the differences between our results and that previously reported include the stimulus used, as H 2 O 2 has pleiotropic effects on cell physiology, including Ca 2+ transport physiology [19] [20] [21] [22] [23] and/or cell type-dependent differences in Ca 2+ transport physiology.
In summary, we have developed a cell-based fluorescence assay for human TRPM2 channel gating based on a clonal isolate of the DT40 suspension culture cell line transfected with the human TRPM2 cDNA-DT40-TRPM2 cells. This assay applies the fluorescence Ca 2+ indicator, Fluo-4 NW, as a readout of TRPM2 channel activity and provides a reliable and reproducible signal in response to 2 known TRPM2 channel activators. This assay should be useful for the identification of potential human TRPM2 ion channel modulators from large compound libraries.
